Today is World Tuberculosis (TB) Day. As the coronavirus (COVID-19) pandemic spreads, our teams around the world are focused on those who are especially vulnerable during this and every outbreak, like all of our tuberculosis patients with compromised immune systems and in urgent need of medical care.

For decades, treatment for drug-resistant tuberculosis was grim. Older, toxic drugs with debilitating side effects were the only option. Until bedaquiline.

Bedaquiline is a groundbreaking drug, created with significant taxpayer funding and with help from the nonprofit and philanthropic medical community—including Doctors Without Borders—that offers drug-resistant TB patients far better chances of being cured.

But it’s so expensive that only one in five patients who need it can afford it.

That’s why Doctors Without Borders is launching a global action campaign: We’re calling on Johnson & Johnson, the pharmaceutical corporation that holds the patent, to lower the price of bedaquiline to $1 per day. And we’ve set an ambitious goal to gather 3,000 petition signatures before midnight—will you join us right now?

Sign the petition. Demand that Johnson & Johnson lower the price of this lifesaving tuberculosis drug!